In the 15th and final chapter of its series on Johnson & Johnson’s Risperdal (risperidone), the Huffington Post (10/2) “Highline” recounts how the jury in the Pledger case handed down its verdict Feb. 24, 2015, finding J&J was negligent by failing to provide an adequate warning about the risk of […]
Johnson & Johnson
7 posts
By Kim Truongle – AMS – Our firm is part of a multi-firm settlement with AMS. If you are one of our AMS clients and have not yet been contacted by us, your contact information may be outdated, so please contact us at (800) 269-3050. Settlement administration is expected to […]
Posted by Kim Truongle March 9, 2013 – As reported in this blog yesterday, a jury in California returned a verdict for the Plaintiff for nearly $8.34 million. $8 million of that figure was awarded for non-economic damages, including physical pain and emotional suffering and distress. The jury agreed the […]
Posted by Kim Truongle February 27, 2013 – Yesterday, a jury in New Jersey found in favor of a mesh implant Plaintiff, awarding her a $3.35 million verdict. What does this mean for your mesh implant case? This does NOT mean that all mesh cases will gross millions, nor that […]
By Cindy Nations February 22, 2013 – A Class I recall has been issued by DePuy Orthopaedics. This time the product involved is a device used in conjunction with the LPS System, an end-stage revision knee product. Reportedly, the defectively-designed device can malfunction, which may lead to possible loss of function, […]
Posted by Buck Daniel August 7, 2012 – Federal judges in Mississippi have upheld a decision that grants victory to Johnson & Johnson in a case where the company’s transvaginal mesh product caused severe injuries. In this decision the court ruled that the plaintiff’s doctor would have still implanted the […]
Posted by Shelley J. Blas, The Nations Law Firm June 27, 2012 – In a recently discovered letter, the FDA directed Johnson & Johnson to stop selling their Gynecare Prolift vaginal mesh implant. The letter, written in 2007, warned J&J to take the product off the market as it had not […]